BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23725798)

  • 1. Foundational concepts of cell fate conversion to the hematopoietic lineage.
    Salci KR; McIntyre BA; Bhatia M
    Curr Opin Genet Dev; 2013 Oct; 23(5):585-90. PubMed ID: 23725798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factor-mediated reprogramming toward hematopoietic stem cells.
    Ebina W; Rossi DJ
    EMBO J; 2015 Mar; 34(6):694-709. PubMed ID: 25712209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Converting cell fates: generating hematopoietic stem cells de novo via transcription factor reprogramming.
    Daniel MG; Lemischka IR; Moore K
    Ann N Y Acad Sci; 2016 Apr; 1370(1):24-35. PubMed ID: 26748878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evaluation of putative hematopoietic stem cells derived from human pluripotent stem cells.
    Hexum MK; Tian X; Kaufman DS
    Methods Mol Biol; 2011; 767():433-47. PubMed ID: 21822894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards an understanding of lineage specification in hematopoietic stem cells: a mathematical model for the interaction of transcription factors GATA-1 and PU.1.
    Roeder I; Glauche I
    J Theor Biol; 2006 Aug; 241(4):852-65. PubMed ID: 16510158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haematopoietic stem and progenitor cells from human pluripotent stem cells.
    Sugimura R; Jha DK; Han A; Soria-Valles C; da Rocha EL; Lu YF; Goettel JA; Serrao E; Rowe RG; Malleshaiah M; Wong I; Sousa P; Zhu TN; Ditadi A; Keller G; Engelman AN; Snapper SB; Doulatov S; Daley GQ
    Nature; 2017 May; 545(7655):432-438. PubMed ID: 28514439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor-induced enhancer modulations during cell fate conversions.
    van Oevelen C; Kallin EM; Graf T
    Curr Opin Genet Dev; 2013 Oct; 23(5):562-7. PubMed ID: 23968684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming adult hematopoietic cells.
    Kaneko S; Otsu M; Nakauchi H
    Curr Opin Hematol; 2010 Jul; 17(4):271-5. PubMed ID: 20571391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro hematopoietic differentiation of human embryonic stem cells induced by co-culture with human bone marrow stromal cells and low dose cytokines.
    Wang J; Zhao HP; Lin G; Xie CQ; Nie DS; Wang QR; Lu GX
    Cell Biol Int; 2005 Aug; 29(8):654-61. PubMed ID: 15950498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.
    Schuringa JJ; Wu K; Morrone G; Moore MA
    Stem Cells; 2004; 22(7):1191-204. PubMed ID: 15579639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of hematopoietic stem and progenitor cells from mouse embryonic stem cells, in vitro, supported by ectopic human HOXB4 expression.
    Pilat S; Carotta S; Klump H
    Methods Mol Biol; 2013; 1029():129-47. PubMed ID: 23756947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements.
    Göttgens B; McLaughlin F; Bockamp EO; Fordham JL; Begley CG; Kosmopoulos K; Elefanty AG; Green AR
    Oncogene; 1997 Nov; 15(20):2419-28. PubMed ID: 9395238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming cell fate to pluripotency: the decision-making signalling pathways.
    Sanges D; Cosma MP
    Int J Dev Biol; 2010; 54(11-12):1575-87. PubMed ID: 21305473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid lineage commitment from the hematopoietic stem cell.
    Iwasaki H; Akashi K
    Immunity; 2007 Jun; 26(6):726-40. PubMed ID: 17582345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cells convert into liver cells within days without fusion.
    Jang YY; Collector MI; Baylin SB; Diehl AM; Sharkis SJ
    Nat Cell Biol; 2004 Jun; 6(6):532-9. PubMed ID: 15133469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generating human hematopoietic stem cells in vitro -exploring endothelial to hematopoietic transition as a portal for stemness acquisition.
    Slukvin II
    FEBS Lett; 2016 Nov; 590(22):4126-4143. PubMed ID: 27391301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular reprogramming--lowering gravity on Waddington's epigenetic landscape.
    Takahashi K
    J Cell Sci; 2012 Jun; 125(Pt 11):2553-60. PubMed ID: 22736045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic cytokines, transcription factors and lineage commitment.
    Zhu J; Emerson SG
    Oncogene; 2002 May; 21(21):3295-313. PubMed ID: 12032771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
    Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A
    Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can controlled cellular reprogramming be achieved using microRNAs?
    Sun X; Fu X; Han W; Zhao Y; Liu H
    Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.